EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome sequencing reveals CCDC88A variants in malformations of cortical development and immune dysfunction

Johanna Lehtonen, Anna H Hakonen, Antti Hassinen, Sanne Iversen Lurås, Meri Kaustio, Virpi Glumoff, Francisca Hinrichsen, Weiwei Li, Anna-Maija Sulonen, Sanna Wickman, Henrikki Almusa, Minttu Polso und 7 weitere

Human Molecular Genetics · 2025

DOI: 10.1093/hmg/ddaf081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Johanna Lehtonen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo Science Park, Gaustadalléen 2, Oslo 0349, Norway. Hauptthemen laut MEDLINE: Microfilament Proteins, Vesicular Transport Proteins, Malformations of Cortical Development. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Norway, Finska Läkaresällskapet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malformations of cortical development (MCDs) encompass a diverse group of genetic and clinical disorders. Here, we aimed to determine a genetic etiology for two siblings manifesting MCD, microcephaly, epilepsy, intellectual disability, and susceptibility to infections. A missense variant (NM_018084:c.929A > C, p.Asp310Ala) and an intragenic deletion (exons 14–16) in CCDC88A were identified as compound heterozygous in patients by genome sequencing. Truncating homozygous CCDC88A variants are known to cause an ultra-rare syndrome manifesting with MCD, microcephaly, seizures, and severe neurological impairment. CCDC88A encodes girdin, which is essential for various cell functions, such as actin remodeling and cell proliferation. Western blot analysis showed that the missense variant allele was expressed in fibroblasts at a level compatible with a heterozygous allele, whereas a truncated protein from the deletion allele was barely detectable. Proliferation and wound-healing assays revealed that girdin-deficient fibroblasts proliferated faster and migrated slower than controls. High-content imaging highlighted girdin-deficient fibroblasts as smaller and their actin remodeling disrupted, leading to perinuclear accumulation of endolysosomal organelles. To confirm these cellular phenotypes resulted from girdin loss, CRISPR-Cas9 edited knockout models of healthy fibroblasts were created, replicating the observations in patient cells. Additionally, the siblings exhibited reduced monocytoid and plasmacytoid dendritic cells, suggesting compromised immunity due to girdin deficiency. In summary, the study describes the first case of a CCDC88A missense variant and intragenic deletion associated with MCD. It demonstrates altered immunity and girdin-related cellular changes, such as cell morphology and proliferation-migration dichotomy, in patient and knockout fibroblasts, reinforcing the pathogenic relevance of these variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microfilament ProteinsVesicular Transport ProteinsMalformations of Cortical DevelopmentHumansFibroblastsMaleMicrocephalyFemaleMutation, MissenseIntellectual DisabilityWhole Genome SequencingCell ProliferationEpilepsy

Stichwörter der Autor:innen

CCDC88Aactinopathygirdinimmunodeficiencymalformations of cortical development

Substanzen

Microfilament ProteinsVesicular Transport ProteinsCCDC88A protein, human

Autor:innen und Institutionen

  • Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo Science Park, Gaustadalléen 2, Oslo 0349, Norway.
  • Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Biomedicum 2, Tukholmankatu 8, Helsinki 00290, Finland.
  • Folkhälsan Research Center, Biomedicum 1, Haartmaninkatu 8, Helsinki 00290, Finland.
  • Department of Medical Genetics, Oslo University Hospital, Building 25, Kirkeveien 166 (Ullevål), Oslo 0450, Norway.
  • Department of Clinical Genetics, HUSLAB, HUS Diagnostic Center, Helsinki University Hospital and University of Helsinki, Topeliuksenkatu 32, Helsinki 00290, Finland.
  • Medical Research Laboratory Unit, Faculty of Medicine, University of Oulu, Pentti Kaiteran katu 1, Oulu 90570, Finland.

Förderung

  • Research Council of Norway
  • Finska Läkaresällskapet

Zitieren

APA

Lehtonen, J., Hakonen, A. H., Hassinen, A., Lurås, S. I., Kaustio, M., Glumoff, V., Hinrichsen, F., Li, W., Sulonen, A. M., Wickman, S., Almusa, H., Polso, M., Palomäki, M., Kivirikko, S., Avela, K., Heiskanen, K., Pietiäinen, V., Aittomäki, K., & Saarela, J. (2025). Genome sequencing reveals CCDC88A variants in malformations of cortical development and immune dysfunction. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf081

Vancouver

Lehtonen J, Hakonen AH, Hassinen A, Lurås SI, Kaustio M, Glumoff V, et al. Genome sequencing reveals CCDC88A variants in malformations of cortical development and immune dysfunction. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf081

BibTeX
@article{Lehtonen2025,
  author = {Lehtonen, Johanna and Hakonen, Anna H and Hassinen, Antti and Lurås, Sanne Iversen and Kaustio, Meri and Glumoff, Virpi and Hinrichsen, Francisca and Li, Weiwei and Sulonen, Anna-Maija and Wickman, Sanna and Almusa, Henrikki and Polso, Minttu and Palomäki, Maarit and Kivirikko, Sirpa and Avela, Kristiina and Heiskanen, Kaarina and Pietiäinen, Vilja and Aittomäki, Kristiina and Saarela, Janna},
  title = {Genome sequencing reveals CCDC88A variants in malformations of cortical development and immune dysfunction},
  journal = {Human Molecular Genetics},
  year = {2025},
  doi = {10.1093/hmg/ddaf081}
}
Kostenlos starten →